| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |